Published: 7/9/2020

Akron, Ohio – Smithers, a leading provider of testing, consulting, information, and compliance services, has announced the formation of the Medical Device Testing division.
 
The Medical Device Testing division will consist of Smithers testing and consulting services in North America and Europe with focus on pharmaceutical drug products, combination delivery devices, and other medical products for:

• Extractables and leachables assessments 
• Compliance testing
• Physical and functional testing

As part of the Smithers connected enterprise, the division will be complemented by the deep expertise and rich history in packaging, rubber, and polymer materials. In addition, based on clients’ needs, further expansion is planned in North America and Europe.

“We have experienced continuous growth in the medical device and pharmaceutical industries and listened to the needs and goals of our valued clients in planning for these strategic investments,” said Michael Hochschwender, President & CEO, Smithers. “This division was thoughtfully designed and formed with the goal of focusing and enhancing our expertise in these biomedical industries to expand our testing for our clients as they bring great products to market.”

To understand more about the journey that Smithers is on in the biomedical market, please visit smithers.com.